Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SB team attempts to identify the source of antiparkinsonian activity of SKF-83959

Nov. 13, 1998

Neurobiological Technologies initiates phase IIb trial of memantine

Nov. 13, 1998

SCRAS presents new series of NOS and lipid peroxidation inhibitors

Nov. 13, 1998

Ligand and Elan finalize strategic alliance

Nov. 13, 1998

SB-205553 used to investigate role of 5-HT2C receptor antagonists in PD therapy

Nov. 13, 1998

SPBN: a free radical scavenger with potential in pediatric head trauma

Nov. 12, 1998

Pharmacological profile of the novel, selective kappa-opioid agonist HZ2

Nov. 12, 1998

Preparation and use of new CNS-active series reported by Pharmacia & Upjohn

Nov. 12, 1998

Improved dosage form of selegiline now on the U.K. market

Nov. 11, 1998

Neuroprotective effects of NCC-161, a new neuronal calcium antagonist

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...